Trial Profile
Comparison of efficacy and safety of two natural surfactants, Curosurf and Survanta in treatment of respiratory distress syndrome: A randomized clinical trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2016
Price :
$35
*
At a glance
- Drugs Beractant (Primary) ; Poractant alfa (Primary)
- Indications Respiratory distress syndrome
- Focus Adverse reactions; Therapeutic Use
- 19 Sep 2016 New trial record